Nesoddtangen, Norway

Asa Frostegard

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asa Frostegard. Retrieved from https://idiyas.com/inventor/asa-frostegard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asa Frostegard: Innovator in Nucleic Acid Extraction

Introduction

Asa Frostegard is a notable inventor based in Nesoddtangen, Norway. He has made significant contributions to the field of molecular biology, particularly in the extraction and utilization of nucleic acids. His innovative work has implications for therapeutic developments and novel compound synthesis.

Latest Patents

Asa Frostegard holds a patent for a method for obtaining nucleic acids from an environmental sample. This method results in nucleic acids that can be used in the synthesis of novel compounds. The invention focuses on preparing a library of nucleic acids from samples, which can be utilized for therapeutic purposes. The patent also includes novel vectors and processes for preparing these vectors or recombinant host cells containing the nucleic acids. Furthermore, it outlines methods for detecting specific nucleic acids within the resulting library.

Career Highlights

Frostegard is associated with Aventis Pharma S.A., where he applies his expertise in molecular biology. His work at the company has allowed him to further develop his innovative methods and contribute to advancements in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues, including Pascale Jeannin and François Francou. These partnerships have enhanced his research and development efforts in the field of nucleic acids.

Conclusion

Asa Frostegard's contributions to nucleic acid extraction and utilization represent a significant advancement in molecular biology. His innovative methods have the potential to lead to new therapeutic compounds and enhance our understanding of genetic materials.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…